PDL BioPharma Price Prediction

As of 13th of March 2025 the value of rsi of PDL BioPharma's share price is below 20 indicating that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of PDL BioPharma's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with PDL BioPharma, which may create opportunities for some arbitrage if properly timed.
Using PDL BioPharma hype-based prediction, you can estimate the value of PDL BioPharma from the perspective of PDL BioPharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in PDL BioPharma to buy its stock at a price that has no basis in reality. In that case, they are not buying PDL because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

PDL BioPharma after-hype prediction price

    
  USD 0.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Symbol  PDLI
Name  PDL BioPharma
TypeStock
Country  
 United States
Exchange  NASDAQ

Hype Analysis is not found for PDL BioPharma at this time

We are unable to locate PDL BioPharma hype analysis at this time. If you believe the equity you are trying to look up is valid, please let us know, and we will check it out.

Hype Analysis

Prediction analysis is currently not available

Other Suggestions

P Pandora MediaCompanyDelisted
POWWP Ammo PreferredCompany
PB Prosperity BancsharesCompany
PAI Platinum Asia InvestmentsFund
PY Principal Value ETFETF
PSE ARCA Technology 100Index
PHA Phala NetworkCryptocurrency
P56243AD3 INRSHM 575 03 APR 28Corporate Bond
PAUSD PalladiumCommodity

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Did you try this?

Run Portfolio Backtesting Now

   

Portfolio Backtesting

Avoid under-diversification and over-optimization by backtesting your portfolios
All  Next Launch Module

PDL BioPharma Additional Predictive Modules

Most predictive techniques to examine PDL price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for PDL using various technical indicators. When you analyze PDL charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Story Coverage note for PDL BioPharma

The number of cover stories for PDL BioPharma depends on current market conditions and PDL BioPharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that PDL BioPharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about PDL BioPharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

PDL BioPharma Short Properties

PDL BioPharma's future price predictability will typically decrease when PDL BioPharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of PDL BioPharma often depends not only on the future outlook of the potential PDL BioPharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PDL BioPharma's indicators that are reflective of the short sentiment are summarized in the table below.
Average Daily Volume In Three Month2.84M
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in PDL Stock

If you are still planning to invest in PDL BioPharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PDL BioPharma's history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
CEOs Directory
Screen CEOs from public companies around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges